1. Home
  2. STE vs TEVA Comparison

STE vs TEVA Comparison

Compare STE & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo STERIS plc (Ireland)

STE

STERIS plc (Ireland)

HOLD

Current Price

$262.94

Market Cap

25.9B

Sector

Health Care

ML Signal

HOLD

Logo Teva Pharmaceutical Industries Limited

TEVA

Teva Pharmaceutical Industries Limited

HOLD

Current Price

$28.43

Market Cap

30.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STE
TEVA
Founded
1985
1901
Country
United States
Israel
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.9B
30.2B
IPO Year
1992
N/A

Fundamental Metrics

Financial Performance
Metric
STE
TEVA
Price
$262.94
$28.43
Analyst Decision
Buy
Strong Buy
Analyst Count
9
8
Target Price
$268.25
$27.00
AVG Volume (30 Days)
674.3K
11.4M
Earning Date
11-05-2025
11-05-2025
Dividend Yield
0.96%
N/A
EPS Growth
59.39
N/A
EPS
6.97
0.62
Revenue
$5,702,415,000.00
$16,776,000,000.00
Revenue This Year
$9.24
$4.74
Revenue Next Year
$6.30
$0.48
P/E Ratio
$37.72
$46.12
Revenue Growth
7.08
0.02
52 Week Low
$200.98
$12.47
52 Week High
$268.60
$28.68

Technical Indicators

Market Signals
Indicator
STE
TEVA
Relative Strength Index (RSI) 59.06 80.93
Support Level $256.68 $24.01
Resistance Level $268.60 $26.96
Average True Range (ATR) 4.64 0.68
MACD -0.69 0.19
Stochastic Oscillator 65.59 94.65

Price Performance

Historical Comparison
STE
TEVA

About STE STERIS plc (Ireland)

Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Share on Social Networks: